Targeted therapies: Denileukin diftitox-a step towards a 'magic bullet' for CTCL

Marshall E. Kadin, Eric C. Vonderheid

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)430-432
Number of pages3
JournalNature Reviews Clinical Oncology
Volume7
Issue number8
DOIs
StatePublished - Aug 2010

Fingerprint

Interleukin-2 Receptor alpha Subunit
Recombinant Fusion Proteins
Diphtheria Toxin
Cutaneous T-Cell Lymphoma
Magic
Interleukin-2 Receptors
Skin Neoplasms
Regulatory T-Lymphocytes
Antineoplastic Agents
Interleukin-2
Immunohistochemistry
Therapeutics
denileukin diftitox

ASJC Scopus subject areas

  • Oncology

Cite this

Targeted therapies : Denileukin diftitox-a step towards a 'magic bullet' for CTCL. / Kadin, Marshall E.; Vonderheid, Eric C.

In: Nature Reviews Clinical Oncology, Vol. 7, No. 8, 08.2010, p. 430-432.

Research output: Contribution to journalArticle

Kadin, Marshall E. ; Vonderheid, Eric C. / Targeted therapies : Denileukin diftitox-a step towards a 'magic bullet' for CTCL. In: Nature Reviews Clinical Oncology. 2010 ; Vol. 7, No. 8. pp. 430-432.
@article{173b0d0a92e04fe6ae05ed7434f886a9,
title = "Targeted therapies: Denileukin diftitox-a step towards a 'magic bullet' for CTCL",
author = "Kadin, {Marshall E.} and Vonderheid, {Eric C.}",
year = "2010",
month = "8",
doi = "10.1038/nrclinonc.2010.105",
language = "English (US)",
volume = "7",
pages = "430--432",
journal = "Nature Clinical Practice Oncology",
issn = "1759-4774",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Targeted therapies

T2 - Denileukin diftitox-a step towards a 'magic bullet' for CTCL

AU - Kadin, Marshall E.

AU - Vonderheid, Eric C.

PY - 2010/8

Y1 - 2010/8

UR - http://www.scopus.com/inward/record.url?scp=77955130383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955130383&partnerID=8YFLogxK

U2 - 10.1038/nrclinonc.2010.105

DO - 10.1038/nrclinonc.2010.105

M3 - Article

C2 - 20668480

AN - SCOPUS:77955130383

VL - 7

SP - 430

EP - 432

JO - Nature Clinical Practice Oncology

JF - Nature Clinical Practice Oncology

SN - 1759-4774

IS - 8

ER -